Adenovirus-mediated targeted expression of toxic genes to adrenocorticotropin-producing pituitary tumors using the proopiomelanocortin promoter

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3400-3409

  Lee, Eun Jig ^a   Martinson, Fred ^a   Kotlar, Tom ^a   Thimmapaya, Bayar ^a   Jameson, J Larry ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GANCICLOVIR; PROOPIOMELANOCORTIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CUSHING SYNDROME; CYTOTOXICITY; EMBRYO; ENDOCRINE TUMOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSGENE;

ADENOVIRIDAE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; DNA, RECOMBINANT; GANCICLOVIR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PITUITARY NEOPLASMS; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS); SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034920085     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3400     Document Type: Article

References (38)

1. Cushing syndrome. Differential diagnosis and treatment
2. Gadolinium DTPA enhanced magnetic resonance imaging of pituitary adenomas in patients with Cushing's disease: Initial experience
3. Gadolinium enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland
4. General aspects of the management of pituitary tumors by surgery or radiation therapy
5. Results of treating childhood Cushing's disease with pituitary irradiation
6. Sustained remission of Cushing's disease with mitotane and pituitary irradiation
7. Gene therapy strategies for the treatment of pituitary tumors
8. Cell-type specific expression in the pituitary: Physiology and gene therapy
9. Targeted expression of toxic genes directed by pituitary hormone promoters: A potential strategy for adenoviral-mediated gene therapy of pituitary tumors
10. Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: Implication for gene therapy
11. Transcriptional targeting to anterior pituitary lactotrophic cells using recombinant adenovirus vectors in vitro and in vivo in normal and estrogen/sulpiride-induced hyperplastic anterior pituitaries
12. Adenovirus-mediated herpes simplex virus typed thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas
13. ACTH. Normal physiology
14. Manupulation of adenovirus vectors
15. Metabolic activation of the nucleoside analog 9-[(2-hyroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus
16. Tumor chemosensitivity conferred by inserted herpes thymidine kinase gene: Paradigm for a prospective cancer control strategy
17. Suicide genes: Gene therapy applications using enzyme/prodrug strategies
18. Enhancer and promoter element interactions dictate cyclic adenosine monophosphate mediated and cell-specific expression of the glycoprotein hormone alpha-gene
19. Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone alpha-subunit promoter
20. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice
21. Regulation of proopiomelanocortin gene expression
22. Authentic cell-specific and developmentally regulated expression of proopiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice
23. Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice
24. Tissue specific activity of the pro-opiomelanocortin gene promoter
25. Pituitary-specific expression and glucocorticoid regulation of a proopiomelanocortin fusion gene in transgenic mice
26. Pituitary specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice
27. Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNA encoding the adrenocorticotropin receptor and aldosterone synthase in mouse adrenal gland
28. Rat and mouse proopiomelanocortin gene sequences target tissue-specific expression to the pituitary gland but not to the hypothalamus of transgenic mice
29. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene
30. Mechanism of action and selectivity of acyclovir
31. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase
32. Phosphorylation of acyclovir diphosphate by cellular enzyme
33. Comparative in vivo genotoxicity of antiviral nucleotide analoques; penciclovir, ganciclovir and xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay
34. Cytogenetic genotoxicity of the antiherpes virostatics in Chinese hamster V70-E cells. I. Purine nucleotide analogues
35. Acyclic guanosine analogs inhibiy DNA polymerase α, β and ε with very different potencies and have unique mechanisms of action
36. Transplantation of ACTH-secreting pituitary tumor cells in athymic nude mice
37. Adenovirus-mediated retinoblastoma gene therapy suppress spontaneous pituitary melanotroph tumors in Rb+/-mice
38. Transgenic mice that develop pituitary tumors. A model for Cushing's disease